The 15 references in paper V. Nevzorova A., T. Tilik V., E. Gilifanov A., S. Vakhrusheva E., E. Panchenko A., V. Kudryavtseva A., P. Lukyanov A., В. Невзорова А., Т. Тилик В., Е. Гилифанов А., С. Вахрушева Е., Е. Панченко А., В. Кудрявцева А., П. Лукьянов А. (2014) “СОДЕРЖАНИЕ СВОБОДНОЙ МЕТАЛЛОПРОТЕИНАЗЫ MMP9 И КОМПЛЕКСА MMP9/TIMP1 В СЫВОРОТКЕ КРОВИ ПРИ СТАБИЛЬНОМ ТЕЧЕНИИ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИ ЛЕГКИХ, АССОЦИИРОВАННОЙ С ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА // CONCENTRATION OF FREE METALLOPROTEINASE MMP9 AND COMPLEX MMP9/TIMP1 IN BLOOD SERUM IN PATIENTS WITH CO-EXISTING STABLE CHRONIC OBSTRUCTIVE LUNG DISEASE AND ISCHEMIC HEART DISEASE” / spz:neicon:pulmonology:y:2011:i:2:p:75-80

1
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI / WHO workshop report. Last update 2008.
(check this in PDF content)
2
Huiart L., Ernst P., Suissa S.Cardiovascular morbidity and mortality in COPD. Chest 2005; 128: 2640–2646.
(check this in PDF content)
3
Curkendall S.M., Lanes S., de Luise C. et al. Chronic obstructive pulmonary disease severity and cardiovascular outcomes. Eur. J. Epidemiol. 2006; 21 (11): 803–813.
(check this in PDF content)
4
Oikonomidi S., Kostikas K., Tsilioni I. et al. Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications. Curr. Med. Chem. 2009; 16 (10): 1214–1228.
(check this in PDF content)
5
Atkinson J.J., Senior R.M. Matrix metalloproteinase-9 in lung remodeling. Am. J. Respir. Cell Mol. Biol. 2003; 28: 12–24.
(check this in PDF content)
6
Zouridakis E., Avanzas P., Arroyo*Espliguero R. et al. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004; 110 (13): 1747–1753.
(check this in PDF content)
7
Agusto A.G.N., Noguera A., Sauleda J. et al. Systemic effects of chronic obstructive pulmonary disease. Eur. Respir. J. 2003; 21: 347–360.
(check this in PDF content)
8
Morris A., Kinnear G., Wan W. Y. et al.Comparison of cigarette smoke-induced acute inflammation in multiple strains of mice and the effect of a matrix metalloproteinase inhibitor on these responses. J. Pharmacol. Exp. Ther. 2008; 327 (3): 851–862.
(check this in PDF content)
9
Mercer P.F. The role of matrix metalloproteinase-9 in the pathogenesis of chronic obstructive pulmonary disease. Dissertat. Abstr. Int.: Proquest 2003; 63 (3): 437.
(check this in PDF content)
10
Agusto A.G.N., Noguera A., Sauleda J. et al.Systemic inflammation in chronic respiratory disease. J. Nutr. Metab. Chron. Respir. Dis. 2003; 24: 46–55.
(check this in PDF content)
11
Churg A., Wang R.D., Tai H. et al. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-release. Am. J. Respir. Crit. Care Med. 2003; 167: 1083–1089.
(check this in PDF content)
12
Kim S.E., Thanh Thuy T.T., Lee J.H. et al. Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract. Exp. Mol. Med. 2009; 41 (4): 277–287.
(check this in PDF content)
13
Pons A.R., Sauleda J., Noguera A. et al.Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmonary disease. Eur. Respir. J. 2005; 26: 60–66.
(check this in PDF content)
14
Brajer B., Kuznar*Kaminska B., Nowicka A. et al. Increased concentration of matrix metalloproteinase-9 in serum of COPD patients. Eur. Respir. J. 2005; 26 (49): 54.
(check this in PDF content)
15
Barkhatova D.A., Nevzorova V.A., Shekunova O.I., Brod* skaya T.A.Сytokines, extracellular matrix metalloproteinases and arterial stiffness in COPD. 18-th European respiratory society annual congress: Abstracts. Berlin; 2008. 589.
(check this in PDF content)